Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Jacobs · SciRah

Researcher profile · Semantic Scholar

M. Jacobs

Share profile

M. Jacobs — researcher profile on SciRah

h-index: 7
Works: 24
Citations: 252

Most-cited papers

Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands
M. Jacobs, F. Kaasenbrood, M. Postma, M. van Hulst +1 more
2016Europace100 citations Open access
Semantic Scholar
Leveraging the Similarities Between Cost-Effectiveness Analysis and Value-Based Healthcare.
Jelle Walraven, M. Jacobs, C. Uyl-de Groot
2021Value in Health25 citations Open access
Semantic Scholar
Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions
M. Jacobs, M. van Hulst, Z. Campmans, R. Tieleman
2019Netherlands Heart Journal23 citations Open access
Semantic Scholar
Incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit
M. Jacobs, B. Loef, A. Reidinga, M. Postma +2 more
2020Open Heart21 citations Open access
Semantic Scholar
Atrial Fibrillation in Africa-An Underreported and Unrecognized Risk Factor for Stroke: A Systematic Review.
M. Jacobs, M. van Hulst, A. Adeoye, R. Tieleman +2 more
2019Global Heart19 citations Open access
Semantic Scholar
Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands
M. Jacobs, Jeroen F Schouten, P. D. de Boer, M. Hoffmann +2 more
2018Current Medical Research and Opinion14 citations Open access
Semantic Scholar
Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation
M. Jacobs, L. D. de Jong, M. Postma, R. Tieleman +1 more
2017European Journal of Health Economics12 citations Open access
Semantic Scholar
Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands
M. van Hulst, R. Tieleman, L. Zwart, M. Pomp +6 more
2022European Heart Journal - Quality of Care and Clinical Outcomes7 citations Open access
Semantic Scholar
The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands
M. van Hulst, J. Stevanović, M. Jacobs, R. Tieleman +2 more
2018Journal of Medical Economics6 citations Open access
Semantic Scholar
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
M. Jacobs, R. Tieleman
2018Netherlands Heart Journal6 citations Open access
Semantic Scholar
Lean Body Mass and Total Body Weight Versus Body Surface Area as a Determinant of Docetaxel Pharmacokinetics and Toxicity
R. Hoge, Suzan E. H. Detert Oude Weme, W. Vervenne, I. R. F. van Berlo-van de Laar +6 more
2022Therapeutic Drug Monitoring4 citations Open access
Semantic Scholar
Screening for Atrial Fibrillation in Sub-Saharan Africa: A Health Economic Evaluation to Assess the Feasibility in Nigeria
M. Jacobs, A. Adeoye, M. Owolabi, R. Tieleman +2 more
2021Global Heart4 citations Open access
Semantic Scholar
Perioperative bridging of vitamin K antagonist treatment in patients with atrial fibrillation: only a very small group of patients benefits.
S. van der Pol, M. Jacobs, K. Meijer, M. Piersma-Wichers +3 more
2019Europace3 citations Open access
Semantic Scholar
Letter responding to Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Societad Latinoamericana de Estimulation Cardiaca y Electrofisiologia (SOLAECE).
M. Jacobs, M. van Hulst, R. Tieleman
2018Europace3 citations Open access
Semantic Scholar
Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands
M. Jacobs, M. W. J. van Leent, R. Tieleman, F. G. Jansman +3 more
2017Journal of Medical Economics3 citations Open access
Semantic Scholar
Ready-to-use parenteral amiodarone: a feasibility study towards a long-term stable product formulation
M. Jacobs, M. Luinstra, J. Moes, Tiffany C Y Chan +3 more
2016European Journal of Hospital Pharmacy: Science and Practice1 citations Open access
Semantic Scholar
Abstract 11651: Cost-effectiveness of Screening for Atrial Fibrillation in Primary Care With a Hand-held, Single-lead ECG Device in the Netherlands
M. Jacobs, F. Kaasenbrood, M. Postma, M. van Hulst +1 more
2016Circulation1 citations
Semantic Scholar
Leveraging the Similarities Between Cost-Effectiveness Analysis and Value-Based Healthcare.
Jelle Walraven, M. Jacobs, C. Uyl-de Groot
2022Value in Health0 citations Open access
Semantic Scholar
Anticoagulation in Atrial Fibrillation: Consideration for treatment and health economic aspects
M. Jacobs
20200 citations Open access
Semantic Scholar
1202The incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit
M. Jacobs, B. Loef, A. Reidinga, M. Postma +2 more
2019European Heart Journal0 citations
Semantic Scholar
PCV135 - NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS PRESCRIPTION MONITORING: HOW TO OPTIMIZE VIGILANCE IN STROKE PREVENTION
M. Jacobs, M. van Hulst, Z. Campmans, R. Tieleman
2018Value in Health0 citations Open access
Semantic Scholar
University of Groningen Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention
M. Jacobs, R. Tieleman
20180 citations
Semantic Scholar
17th Biennial European Meeting of the Society for Medical Decision Making Leiden, the Netherlands, June 10–12, 2018
S. van der Pol, M. Jacobs, K. Meijer, M. Piersma-Wichers +3 more
2018Medical decision making0 citations Open access
Semantic Scholar
Health Economic Evaluation Of Elective Cardioversion Of Atrial Fibrillation With Rivaroxaban Versus Vitamin K Oral Antagonists
M. Jacobs, L. D. de Jong, M. Postma, R. Tieleman +1 more
20170 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. van Hulst×16
Invite
M. van Hulst — researcher profile on SciRah
R. Tieleman×14
Invite
R. Tieleman — researcher profile on SciRah
M. Postma×9
Invite
M. Postma — researcher profile on SciRah
R. Tieleman×4
Invite
R. Tieleman — researcher profile on SciRah

×2

Invite

F. Kaasenbrood — researcher profile on SciRah

Jelle Walraven×2

Invite

Jelle Walraven — researcher profile on SciRah

C. Uyl-de Groot×2

Invite

C. Uyl-de Groot — researcher profile on SciRah

Invite

Z. Campmans — researcher profile on SciRah

Invite

B. Loef — researcher profile on SciRah

Invite

A. Reidinga — researcher profile on SciRah

Invite

A. Adeoye — researcher profile on SciRah

Invite

M. Owolabi — researcher profile on SciRah